A carregar...
Gonadotropin-Releasing Hormone Antagonist in the Management of Prostate Cancer
Luteinizing hormone-releasing hormone (LHRH) agonist therapy to induce medical castration has become the most common form of hormonal therapy for advanced and metastatic prostate cancer. When treatment is started, LHRH agonists initially stimulate the release of LH, causing a surge in serum testoste...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MedReviews, LLC
2004
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1472892/ https://ncbi.nlm.nih.gov/pubmed/16985933 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|